Publication date: May 31, 2025
Myocarditis and pericarditis following mRNA COVID-19 vaccines have occurred most commonly in males 12 years through 24 years of age. For this reason, your healthcare provider may ask you to stay for a short time at the place where you received your vaccine. A severe allergic reaction would usually occur within a few minutes to 1 hour after getting a dose of mNEXSPIKE. Participants received either a 10 g dose of mRNA-1283 or a 50 g dose of mRNA-1273. Ask your healthcare provider about any side effects that concern you. COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone.
Concepts | Keywords |
---|---|
Breastfeedinghave | Allergic |
Covid | |
Fda | Dose |
Weaknessmyocarditis | Looking |
Mnexspike | |
Moderna | |
Modernas | |
Mrna | |
Older | |
Received | |
Severe | |
Statements | |
Vaccine | |
Vaccines | |
Years |
Semantics
Type | Source | Name |
---|---|---|
pathway | REACTOME | Release |
disease | IDO | blood |
disease | MESH | bleeding |
disease | MESH | pain joint |
disease | MESH | Injection site reactions |
disease | MESH | Myocarditis |
disease | MESH | pericarditis |
disease | MESH | inflammation |
disease | MESH | allergic reaction |
drug | DRUGBANK | Coenzyme M |
disease | MESH | rare diseases |
disease | MESH | autoimmune diseases |
drug | DRUGBANK | Nonoxynol-9 |
disease | MESH | COVID-19 |
disease | IDO | site |
disease | MESH | infectious diseases |